These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8438397)

  • 1. Cyclosporine and rapamycin block protein kinase C-mediated induction of the activation signal, activator of DNA replication, in cell-free assay.
    Kimball P; Kerman RH; Williams J; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):518-9. PubMed ID: 8438397
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine and rapamycin affect protein kinase C induction of the intracellular activation signal, activator of DNA replication.
    Kimball PM; Kerman RK; Van Buren CT; Lewis RM; Katz S; Kahan BD
    Transplantation; 1993 May; 55(5):1128-32. PubMed ID: 8497893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
    Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
    Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
    [No Abstract]   [Full Text] [Related]  

  • 4. P70 S6 kinase assay: a pharmacodynamic monitoring strategy for rapamycin; assay development.
    Gallant HL; Yatscoff RW
    Transplant Proc; 1996 Dec; 28(6):3058-61. PubMed ID: 8962186
    [No Abstract]   [Full Text] [Related]  

  • 5. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapamycin suppresses in vitro immunoglobulin production by human lymphocytes.
    Luo H; Chen H; Daloze P; Chang J; Wu J
    Transplant Proc; 1991 Aug; 23(4):2236-8. PubMed ID: 1871858
    [No Abstract]   [Full Text] [Related]  

  • 7. Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury.
    Puglisi RN; Strande L; Santos M; Schulte G; Hewitt CW; Whalen TV
    J Surg Res; 1996 Oct; 65(2):115-8. PubMed ID: 8903456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
    Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
    Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
    Bierer BE
    Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.
    Wu J; Palladino MA; Figari IS; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):238-40. PubMed ID: 1703683
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitors of protein kinase C block activation of B lymphocytes by bacterial lipopolysaccharide.
    Rush JS; Waechter CJ
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1315-20. PubMed ID: 3496881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular pharmacology on protein kinase C].
    Hidaka H; Naka M
    Tanpakushitsu Kakusan Koso; 1986 May; 31(6):534-48. PubMed ID: 3529244
    [No Abstract]   [Full Text] [Related]  

  • 13. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
    Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
    Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesiveness and proliferation of epithelial cells are differentially modulated by activation and inhibition of protein kinase C in a substratum-dependent manner.
    Zhou Y; Dziak E; Opas M
    J Cell Physiol; 1993 Apr; 155(1):14-26. PubMed ID: 8468359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD; Lerner CG; Schwartz RH
    J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin effects on immunologic reconstitution.
    Vogelsang GB; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of action of rapamycin (Sirolimus, Rapamune).
    Molnar-Kimber KL
    Transplant Proc; 1996 Apr; 28(2):964-9. PubMed ID: 8623482
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture.
    Seidel ER; Ragan VL
    Br J Pharmacol; 1997 Feb; 120(4):571-4. PubMed ID: 9051292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin.
    Carlson RP; Sehgal SN; Lewis AJ
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S129. PubMed ID: 8324938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.